(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GENECENTRIC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GENECENTRIC

ST13

US500000088980283

Class

42

Filing

88980283

Registration

6487493

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

09/14/2021

Trademark type

Word

Nice classes

42

Filing date

11/27/2019

Registration date

09/14/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/14/2021

Last transaction

09/14/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2011-06-00

First use in commerce

2011-06-00

Drawing code

4

Owner type

03

Owner location

Research Triangle Park, NC

Examiner

MORRIS, ALINA

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

GENECENTRIC THERAPEUTICS, INC.

Representatives

Devon E. White WYRICK ROBBINS YATES & PONTON LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Providing medicalscientific and pharmaceutical research services; Providing medical research and scientific research information in the field of oncology; Providing medical and scientific research services in the field of cancer diagnosisprognosistherapypreventiontreatment and patient management; Providing research and development services in the pharmaceutical and biotechnology fields; Research and development services in the field of gene expressioncancer biology; Providing medical and scientific research services and information in the field of clinical trials; Research and development services for othersresearch and development of assays for oncological testingtreatment and diagnostic purposes; Scientific research in the field of genome sequence analysis and reporting; Medical laboratory testing services; Providing genome sequencingdata analysis and interpretationassay development and preparingamplifyinglabelingdetectinganalyzing and sequencing nucleic acids and other biological moleculesresearch and design relating theretoall in the field of bioinformaticsgenomics and gene expression research and development

Publications

History of USPTO decisions and trademark events.

32 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

09/14/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/10/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/09/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/07/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/06/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/06/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/09/2021

GNRT

NON-FINAL ACTION E-MAILED

02/09/2021

CNRT

SU - NON-FINAL ACTION - WRITTEN

02/09/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/21/2021

DPCC

DIVISIONAL PROCESSING COMPLETE

01/21/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/14/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/23/2020

IUAF

USE AMENDMENT FILED

10/28/2020

DRRR

DIVISIONAL REQUEST RECEIVED

10/28/2020

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

10/28/2020

EISU

TEAS STATEMENT OF USE RECEIVED

10/28/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/28/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/03/2020

PUBO

PUBLISHED FOR OPPOSITION

03/03/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/12/2020

ALIE

ASSIGNED TO LIE

01/27/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/21/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/18/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/17/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/17/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/23/2019

GNRT

NON-FINAL ACTION E-MAILED

12/23/2019

CNRT

NON-FINAL ACTION WRITTEN

12/23/2019

DOCK

ASSIGNED TO EXAMINER

12/17/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/05/2019

NWAP

NEW APPLICATION ENTERED

11/30/2019

Continuous trademark protection

Get notified about every new filing that threatens GENECENTRIC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.